1. ADHD drugs: risk of cardiovascular events

   News item 27 February 2016 Pages: 1 - 1

2. Increased risk of venous thromboembolism with cisplatin

   News item 27 February 2016 Pages: 2 - 2

3. Japan's PMDA releases investigation results for 4 products

   News item 27 February 2016 Pages: 3 - 3

4. New rules on monitoring ADRs of biologicals in Denmark

   News item 27 February 2016 Pages: 4 - 4

5. PRAC recommends revoking authorisation of fusafungine

   News item 27 February 2016 Pages: 5 - 5

6. Risk of PML with natalizumab: PRAC recommendations

   News item 27 February 2016 Pages: 6 - 6

7. SGLT2 inhibitor-related risk of diabetic ketoacidosis

   News item 27 February 2016 Pages: 7 - 7

8. Signal strengthened for vemurafenib-associated AF?

   News item 27 February 2016 Pages: 8 - 8

9. Antibacterial-associated encephalopathy: three types

   Clinical study 27 February 2016 Pages: 9 - 9

10. Risks of incretin-based drugs in patients with T2DM examined

    Review 27 February 2016 Pages: 10 - 10

11. Safety of atorvastatin 80 mg/day assessed in meta-analysis

    Review 27 February 2016 Pages: 11 - 11

12. Use of PPIs in elderly may increase risk of dementia

    Clinical study 27 February 2016 Pages: 12 - 12

13. Abciximab/aspirin/clopidogrel

    Case report 27 February 2016 Pages: 13 - 13

14. Acitretin

    Case report 27 February 2016 Pages: 14 - 14

15. Aclarubicin/cytarabine

    Case report 27 February 2016 Pages: 15 - 15

16. Adalimumab

    Case report 27 February 2016 Pages: 16 - 16

17. Adalimumab/infliximab

    Case report 27 February 2016 Pages: 17 - 17

18. Alendronic acid

    Case report 27 February 2016 Pages: 18 - 18

19. Alendronic acid/zoledronic acid

    Case report 27 February 2016 Pages: 19 - 19

20. Alglucosidase-α

    Case report 27 February 2016 Pages: 20 - 20

21. Allopurinol

    Case report 27 February 2016 Pages: 21 - 21

22. Amiodarone

    Case report 27 February 2016 Pages: 22 - 22

23. Amiodarone

    Case report 27 February 2016 Pages: 23 - 23

24. Amiodarone/vemurafenib

    Case report 27 February 2016 Pages: 24 - 24

25. Amisulpride/haloperidol/risperidone

    Case report 27 February 2016 Pages: 25 - 25

26. Anakinra

    Case report 27 February 2016 Pages: 26 - 26

27. Antiepileptic drugs

    Case report 27 February 2016 Pages: 27 - 27

28. Antineoplastics

    Case report 27 February 2016 Pages: 28 - 28

29. Antineoplastics

    Case report 27 February 2016 Pages: 29 - 29

30. Antineoplastics

    Case report 27 February 2016 Pages: 30 - 30

31. Antipsychotics/metoclopramide

    Case report 27 February 2016 Pages: 31 - 31

32. Apixaban

    Case report 27 February 2016 Pages: 32 - 32

33. Arsenic trioxide/tamibarotene

    Case report 27 February 2016 Pages: 33 - 33

34. Artesunate

    Case report 27 February 2016 Pages: 34 - 34

35. Aspirin

    Case report 27 February 2016 Pages: 35 - 35

36. Aspirin/clopidogrel

    Case report 27 February 2016 Pages: 36 - 36

37. Azathioprine

    Case report 27 February 2016 Pages: 37 - 37

38. Azathioprine

    Case report 27 February 2016 Pages: 38 - 38

39. Azathioprine

    Case report 27 February 2016 Pages: 39 - 39

40. Azathioprine/ciclosporin/prednisone/tacrolimus

    Case report 27 February 2016 Pages: 40 - 40

41. Azathioprine/mycophenolate mofetil/prednisolone/tacrolimus

    Case report 27 February 2016 Pages: 41 - 41

42. Azithromycin

    Case report 27 February 2016 Pages: 42 - 42

43. Azithromycin

    Case report 27 February 2016 Pages: 43 - 43

44. BCG

    Case report 27 February 2016 Pages: 44 - 44

45. Bcg-vaccine

    Case report 27 February 2016 Pages: 45 - 45

46. Bee venom allergy immunotherapy

    Case report 27 February 2016 Pages: 46 - 46

47. Bendamustine

    Case report 27 February 2016 Pages: 47 - 47

48. Benzocaine

    Case report 27 February 2016 Pages: 48 - 48

49. Bortezomib

    Case report 27 February 2016 Pages: 49 - 49

50. Botulinum-toxin-A

    Case report 27 February 2016 Pages: 50 - 50